amp 579

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2004
01219982004

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
We investigated the effects of 1S-[1a,2b,3b,4a(S*)]-4-[7-[[1-[(3-chloro-2-thienyl)methylpropyl]propyl-amino]-3H-imidazo[4,5-b… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2003
2003
The adenosine A(1)/A(2) receptor agonist AMP 579 has been reported to protect the heart against infarction even when administered… (More)
Is this relevant?
2002
2002
AMP 579, an adenosine A /A receptor agonist, is cardioprotective when administered at reperfusion. Pretreatment with the Na /H… (More)
Is this relevant?
2001
2001
To determine the mechanism by which AMP 579, an adenosine A1/A2 agonist, administered at reperfusion protects ischemic myocardium… (More)
Is this relevant?
2001
2001
AMP 579, an adenosine A(1)/A(2) receptor agonist, has a strong anti-infarct effect when administered just before reperfusion… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2000
2000
The novel A(1)/A(2)adenosine receptor agonist AMP 579 has been reported to reduce myocardial infarct size in pig and dog. The… (More)
Is this relevant?
2000
2000
The pharmacokinetics of an adenosine agonist (AMP 579) were characterized in patients with end-stage renal disease compared to… (More)
Is this relevant?
1999
1999
The hemodynamic and cardioprotective properties of the novel adenosine A1/A2 receptor agonist AMP 579 (IS-[1a,2b,3b,4a(S*)]-4-[7… (More)
Is this relevant?
1999
1999
The pharmacokinetics of an adenosine agonist, AMP 579, following intravenous administration were evaluated. Single AMP 579 doses… (More)
Is this relevant?
1998
1998
This study examined the cardioprotective effects and pharmacology of the novel adenosine A1/A2 receptor agonist ([1S-[1a,2b,3b… (More)
Is this relevant?